New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease ("Dry Eye"). RESTASIS® is the first prescription eye drop to target the underlying cause of chronic Dry Eye.